France· FR:62036900
NEOSTIGMINE RENAUDIN 5 mg/5 mL, solution injectable
A medicinal product containing métilsulfate de néostigmine, registered in France by LABORATOIRE RENAUDIN.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- MÉTILSULFATE DE NÉOSTIGMINE
- Manufacturer
- LABORATOIRE RENAUDIN
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip13340092693958810 ampoule(s) en verre de 5 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Métilsulfate de néostigmine in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesBloxiverzExela Pharma Sciences, LLC
- GermanyNeostigCarinopharm Gmbh
- CanadaNEOSTIGMINE METHYLSULFATE INJECTION USPMARCAN PHARMACEUTICALS INC
- BelgiumProstigmine 0.5 mg/mlViatris Healthcare
- NetherlandsNeostigminemethylsulfaat CF 0,5 mg/ml, injectievloeistofCentrafarm B.V.
- NorwayNeostig-carinopharmCarinopharm
- PolandPolstigminumTeva Pharmaceuticals Polska Sp. z o.o.
- CzechiaSYNTOSTIGMINBB Pharma a.s., Praha
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Austria · Neostig, Normastigmin
- Cyprus · Neostigmine Cooper
- Czechia · Syntostigmin
- Germany · Neostig, Neostigmin Panpharma
- Spain · Neostigmina Braun
- United Kingdom (Northern Ireland) · Neostigmine Methylsulfate Bp Hameln Pharma
- Greece · Neostigmine Cooper
- Croatia · Neostigmin Panpharma
- Hungary · Neostigmine Kalceks, Stigmosan
- Latvia · Neostigmine Kalceks
- Netherlands · Neostigminemethylsulfaat Cf, Prostigmin
- Poland · Polstigminum
- Portugal · Neostigmina Braun
- Romania · Miostin
- Sweden · Neostigmin Unimedic Pharma Ab
- Slovakia · Syntostigmin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7b0b293c-8f7f-474c-af56-1b84c9ba0813 GET /v1/drugs/7b0b293c-8f7f-474c-af56-1b84c9ba0813?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "62036900",
"date_amm": "2013-02-27",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "MÉTILSULFATE DE NÉOSTIGMINE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "intramusculaire;intraveineuse;sous-cutanée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about métilsulfate de néostigmine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.